Executives On The Move: Bayer Adds Two New VPs and Science Leader at Janssen R&D Leaves for New Opportunity
Executive Summary
Bayer adds new VPs in Government Relations and US Corporate Engagement from Monsanto. And at Janssen R&D, Global Head, Discovery Sciences moves to CSO position at Incyte Corp. Meanwhile, Axovant Sciences revamps its team.
You may also be interested in...
Pipeline Watch: 16 Approvals And 21 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: New Hires At Everest Medicines, Arvinas, Fulcrum Therapeutics And More
Recent executive changes in the industry include seven new chief medical officers, and new chief commercial officers at Adaptimmune Therapeutics and Syndax Pharmaceuticals.
The 2024 Scrip Awards Is Open For Entries
Entries for the Scrip Awards are now open. Now in their 20th year, the Awards seek to reward the outstanding achievements of the pharmaceutical, biotech and allied industries in improving human health.